Simplify Logo

Full-Time

Scientist – MS&T

Updated on 10/1/2024

Legend Biotech

Legend Biotech

1,001-5,000 employees

Develops and commercializes cell therapies

Biotechnology
Healthcare

Mid, Senior

Somerset County, NJ, USA

Position requires onsite presence in Somerset, NJ.

Category
Public Health
Biology Lab & Research
Biology & Biotech
Required Skills
Data Analysis
Requirements
  • Bachelor's or master's degree in Biochemistry, Biotechnology, Chemical Engineering, or a related field
  • 2-5 years of experience in MS&T, process development, or a related field
  • Strong understanding of cell therapy, automation, and bioprocessing principles
  • Excellent communication and project management skills
  • Ability to work effectively in a fast-paced, dynamic environment
  • Knowledge of automation technologies and GMP practices is a plus
  • Experience in analytical assays such as flow cytometry, qPCR, ELISA, and other assays is highly desired
  • Experience with CAR-T cell therapy or similar cellular therapy products
  • Familiarity with design of experiments (DOE) and statistical process control (SPC)
  • Experience with data analytics and visualization tools
Responsibilities
  • Assist in designing and executing process development experiments
  • Author and review technical documents, protocols, and reports
  • Analyze and present data in a clear and concise manner
  • Ensure GMP compliance in laboratory notebooks, protocols, and reports
  • Collaborate with internal and external partners to evaluate and implement new process technologies
  • Support technology transfer activities to ensure successful implementation of new processes or technologies in GMP manufacturing environments
  • Assist in implementing automation technologies to enhance process efficiency and productivity
  • Collaborate with cross-functional teams to ensure successful implementation of GMP practices and procedures
  • Perform and interpret analytical assays such as flow cytometry, qPCR, ELISA, and other assays to support process development and optimization

Legend Biotech develops and sells cell therapies aimed at treating serious diseases, particularly cancers like hematological malignancies and solid tumors. Their approach is technology agnostic, allowing them to explore various methods to find effective treatments. The company operates in the personalized medicine sector, focusing on discovering, developing, and bringing new therapies to market. They generate revenue through licensing and selling their therapies, including CAR-T therapies, which involve modifying a patient's own cells to combat cancer. Unlike many competitors, Legend Biotech emphasizes transparency with investors, regularly updating them on financial results and business developments. Their goal is to provide effective treatments for hard-to-treat diseases through innovative cell therapy solutions.

Company Stage

IPO

Total Funding

$750.5M

Headquarters

Franklin Township, New Jersey

Founded

2014

Growth & Insights
Headcount

6 month growth

17%

1 year growth

41%

2 year growth

96%
Simplify Jobs

Simplify's Take

What believers are saying

  • Legend Biotech's recent European Commission approval for CARVYKTI® positions it as a leader in the multiple myeloma treatment market.
  • Strategic partnerships, such as the one with MaxCyte, enhance Legend Biotech's capabilities in cell engineering and expand its technological reach.
  • The company's commitment to transparency and investor relations, demonstrated through regular financial updates, fosters investor confidence and long-term stability.

What critics are saying

  • The competitive landscape in cell therapy and personalized medicine is intense, requiring continuous innovation to maintain market position.
  • Regulatory hurdles and the need for extensive clinical trials can delay the commercialization of new therapies, impacting revenue streams.

What makes Legend Biotech unique

  • Legend Biotech's technology-agnostic approach allows it to explore multiple innovative therapies, unlike competitors who may focus on a single technology.
  • The company's comprehensive business model, from discovery to commercialization, ensures control over the entire treatment lifecycle, providing a competitive edge.
  • Legend Biotech's strong focus on CAR-T therapies, particularly for hematological malignancies and solid tumors, sets it apart in the personalized medicine sector.